Kaia Health, the US-based developer of a chronic pain management platform, has received $75m in a series C round featuring Optum Ventures, the corporate venture capital arm of healthcare services provider Optum, TechCrunch reported on Wednesday.
The round was led by an undisclosed growth equity fund and it also featured Eurazeo, 3VC, Balderton Capital, Heartcore Capital, Symphony and A Round Capital.
Founded in 2016, Kaia operates a digital platform whichprovides physical exercise insructions and mind and body relaxation techniques for users with chronic musculoskeletal pain conditions.
The company claims its platform is used by more than 450,000 people globally and the capital will be used to support recruitment for its commercial team.
Kaia has raised at least $125m of funding to date, having closed a $26m series B round co-led by Optum Ventures, Idinvest and Capital300 in June 2020 that included Balderton Capital, Symphony Ventures and Heartcore Capital.
Optum Ventures had led an $8m funding round for the company in September 2019, after it had received $10m in series A round led by Balderton Capital in January that year. Kaia also picked up $4m of seed funding from undisclosed investors in 2016.